首页 › 基金 › CVS HEALTH Corp › GDX

CVS HEALTH Corp 对 GDX 的持仓历史

VANECK ETF TRUST

CVS HEALTH Corp 在 Q3 2026 的 13F 申报中披露持有 GDX(VANECK ETF TRUST)5,000 股,市值约 US$439K,约占其申报组合的 0.10%,在其申报持仓中市值排名第 35 位。 CVS HEALTH Corp 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)5.00K 股
申报持仓市值$439.00K
组合权重0.10%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

CVS HEALTH Corp 对 GDX 的持仓演变

CVS HEALTH Corp 于 Q3 2026 首次披露 GDX 持仓:5,000 股(约 US$439K)。

逐季持仓明细

季度股数金额变化
Q3 2026 5.00K $439.00K 新进

关于 GDX 与 13F 数据

GDX(VANECK ETF TRUST)的行业分类暂缺。我们追踪的基金中还有 43 只申报持有 GDX,申报仓位最大的包括:埃利奥特投资管理 (US$690.4M), Rafferty Asset Management, LLC (US$537.9M), Blue Sparrow, LLC /DE (US$294.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GDX 的基金

查看 GDX 的全部基金持有人 →

常见问题

How long has CVS HEALTH Corp held GDX?

CVS HEALTH Corp has disclosed GDX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is CVS HEALTH Corp's current position in GDX?

As of Q3 2026, CVS HEALTH Corp holds 5.00K shares of GDX (VANECK ETF TRUST), valued at $439.00K, representing 0.10% of its reported portfolio and ranking #35.

Has CVS HEALTH Corp been buying or selling GDX?

In the latest 13F filing (Q3 2026), CVS HEALTH Corp newly opened its position in GDX.

Which other funds hold GDX?

Other major institutional holders of GDX include 埃利奥特投资管理, Rafferty Asset Management, LLC, Blue Sparrow, LLC /DE, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.